Shared Facility Audit Findings and CAPA Examples

Audit Findings and CAPA for Shared Facilities in Pharma Manufacturing In the pharmaceutical industry, shared facilities pose unique challenges for quality assurance professionals. Audit findings related to contamination risks in…

How to Manage Shared Facility Risks After Equipment Modification

Effective Strategies for Managing Risks in Shared Facilities Post-Equipment Modification In the increasingly complex landscape of pharmaceutical manufacturing, managing risks associated with shared facilities is crucial, especially following equipment modifications.…

How to Manage Shared Facility Risks After Equipment Modification

Effective Strategies for Managing Risks in Shared Facilities Post-Equipment Modification In the pharmaceutical industry, equipment modifications are often necessary to enhance productivity, incorporate new technologies, or comply with regulatory changes.…

Shared Facility Risk Assessment for Product Introduction

Assessing Risks in Shared Facilities for Product Introduction In the pharmaceutical industry, shared facilities often pose complex challenges when introducing new products. The risks associated with cross-contamination, inadequate segregation, and…

How to Qualify Shared Equipment for Multiple Products

Effective Strategies for Qualifying Shared Equipment Across Multiple Products In a landscape where cross-contamination risks in shared facilities loom large, professionals in pharmaceutical manufacturing must devise effective strategies to ensure…

Shared Facility Change Control Triggers for New Products

Effective Management of Change Control Triggers in Shared Facilities for New Product Introductions As pharmaceutical companies increasingly utilize shared facilities, the potential for cross-contamination and subsequent product integrity issues has…

Shared Facility Change Control Triggers for New Products

Identifying and Addressing Change Control Triggers in Shared Facilities for New Products Implementing new products in a shared facility presents unique challenges, particularly in terms of contamination control and compliance…